Abstract Library

#2020 Expression of Somatostatin Receptors in Neuroendocrine Tumors of the Lungs with Various Degrees of Malignancy

Introduction: Diagnostics and management of patients with neuroendocrine tumors of the lung requires an individual approach

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Gurevich L, Korsakova N, Voronkova I, Kazantseva I, Ashevskaya V,

Keywords: lungs, neuroendocrine tumors, somatostatin receptor, differentiation,

#827 Neuroendocrine Tumors of the Pancreas Grade 2 with Ki-67 Index More Than 5% and with Expression Cytokeratin 19 are the Risk Group of Rapid Progression

Introduction: Cytokeratin 19 (CK19) is the marker of pluripotent cells of the epithelium of the pancreatic ducts, which is not detected in differentiated endocrine cells. Our experience shows that many patients with neuroendocrine tumors of the pancreas (pNET) G2 have a rapid progression of the disease a few years after diagnosis, and metastases are found most commonly in the liver.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Gurevich L, Korsakova N, Kazantseva I, Egorov A, Britvin T,

Keywords: pancreas, neuroendocrine tumors, risk factors, Ki-67, cytokeratin 19,

#689 Immunohistochemical Expression of Somatostatin Receptors 1, 2, 3, and 5 Types (SSR) in Functioning and Non-Functioning Gastroenteropancreatic Neuroendocrine Tumors

Introduction: SSRs are therapeutic targets for the somatostatin analogues in treatment of gasrtroenteropancreatic neuroendocrine tumors (GEP-NET).

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Gurevich L, Kazantseva I, Panteleeva E, Britvin T, Egorov A,

Keywords: neuroendocrine, tumors, somatostatin, receptor,

#419 Morphological Characteristics of Pancreatic Tumors in Children and Young Patients

Introduction: Pancreatic tumors (PT) usually occur after age 60 and almost never in children and young patients (pts). Little is known concerning frequency, morphological and immunohistochemical (IHC) characteristics of PTs in children and young pts.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Gurevich L, Kazantseva I, Korsakova N, Egorov A, Britvin T,

Keywords: pancreatic tumors, young patients, hereditary syndromes, solid-pseudopapillary tumor,

#239 CK 19 Expression in Pancreatic Neuroendocrine Tumors as Negative Prognostic Factor and a Risk Factor for Metastases

Introduction: Neuroendocrine tumors (NET) of the pancreas are slow growing neoplasms, but they can metastasize after many years after surgery.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Gurevich L, Korsakova N, Kazantseva I, Bobrov M, Egorov A,

Keywords: neuroendocrine tumors, CK19 expression, immunohischemistry, prognosis.,